About this FactMed analysis covering adverse side effect reports of COMBIVIR patients who developed AKINESIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking COMBIVIR reported AKINESIA to the FDA. A total of 7443 COMBIVIR drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between COMBIVIR and AKINESIA. In doing so, we compare COMBIVIR with other drugs that cause AKINESIA, to help you evaluate whether or not COMBIVIR causes AKINESIA. Likewise, this page shows the most highly-reported side effects of COMBIVIR, so you can see if AKINESIA ranks among COMBIVIR's most well-known side effects.
Summary Statistics
Reports of COMBIVIR causing AKINESIA: 3
Reports of any side effect of COMBIVIR : 7443
Percentage of COMBIVIR patients where AKINESIA is a reported side effect: 0.0403%

FDA reports of any drug causing AKINESIA : 753
Average percentage for all medicated patients where AKINESIA is reported as a complication: 0.0047%

Physician opinion on COMBIVIR as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing COMBIVIR:
HIV INFECTION ( 3752 patients )
DRUG EXPOSURE DURING PREGNANCY ( 374 patients )
ANTIRETROVIRAL THERAPY ( 257 patients )
ANTIVIRAL TREATMENT ( 198 patients )
ANTIVIRAL PROPHYLAXIS ( 194 patients )
DRUG USE FOR UNKNOWN INDICATION ( 180 patients )
HIV TEST POSITIVE ( 123 patients )
PROPHYLAXIS AGAINST HIV INFECTION ( 102 patients )
PROPHYLAXIS ( 101 patients )
ACQUIRED IMMUNODEFICIENCY SYNDROME ( 100 patients )
MATERNAL EXPOSURE TIMING UNSPECIFIED ( 86 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 70 patients )
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION ( 58 patients )
MATERNAL EXPOSURE DURING PREGNANCY ( 42 patients )
SYSTEMIC ANTIVIRAL TREATMENT ( 28 patients )
RETROVIRAL INFECTION ( 15 patients )
VIRAL INFECTION ( 10 patients )
ACUTE HIV INFECTION ( 9 patients )
ASYMPTOMATIC HIV INFECTION ( 9 patients )
VERTICAL INFECTION TRANSMISSION ( 7 patients )
PATHOGEN RESISTANCE ( 7 patients )
ILL-DEFINED DISORDER ( 4 patients )
ACCIDENTAL NEEDLE STICK ( 4 patients )
LENTIVIRUS TEST POSITIVE ( 3 patients )
PREGNANCY ( 2 patients )
HIV INFECTION CDC CATEGORY A3 ( 2 patients )
EXPOSURE TO COMMUNICABLE DISEASE ( 2 patients )
CASTLEMAN'S DISEASE ( 1 patients )
SEXUALLY TRANSMITTED DISEASE ( 1 patients )
CONGENITAL HIV INFECTION ( 1 patients )
URTICARIA ( 1 patients )
END STAGE AIDS ( 1 patients )
PANCYTOPENIA ( 1 patients )
EXPOSURE VIA BLOOD ( 1 patients )
PNEUMOCYSTIS CARINII INFECTION ( 1 patients )
HIV ANTIBODY POSITIVE ( 1 patients )
BILIARY CIRRHOSIS ( 1 patients )
HIV TEST ( 1 patients )
BITE ( 1 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 1 patients )
IMMUNODEFICIENCY ( 1 patients )
CONVULSION NEONATAL ( 1 patients )
ACCIDENTAL EXPOSURE ( 1 patients )
LOCAL ANTIVIRAL TREATMENT ( 1 patients )
HERPES VIRUS INFECTION ( 1 patients )
PNEUMOCYSTIS JIROVECI INFECTION ( 1 patients )
AUTOIMMUNE DISORDER ( 1 patients )
HIV INFECTION CDC CATEGORY B2 ( 1 patients )
BILIARY CIRRHOSIS PRIMARY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with AKINESIA:

MODOPAR (292 patients)
EFFEXOR (145 patients)
XANAX (129 patients)
VIOXX (116 patients)
STALEVO 100 (111 patients)
ASPIRIN (73 patients)
PERGOLIDE MESYLATE (56 patients)
SINEMET (55 patients)
RISPERDAL (54 patients)
ATHYMIL (52 patients)
COMTAN (45 patients)
MADOPAR (41 patients)
LORAZEPAM (40 patients)
MADOPAR DISPERSIBLE (39 patients)
IMOVANE (38 patients)
ZYPREXA (37 patients)
ATARAX (37 patients)
VALPROATE SODIUM (36 patients)
CLOZAPINE (31 patients)
DEPAKOTE (30 patients)
CITALOPRAM HYDROBROMIDE (29 patients)
CLOBAZAM (29 patients)
FUROSEMIDE (28 patients)
REQUIP (28 patients)
PARLODEL (27 patients)
EXELON (27 patients)
PAXIL (26 patients)
DIGOXIN (25 patients)
LASIX (25 patients)
ERYTHROMYCIN (25 patients)
SEROQUEL (25 patients)
LAMOTRIGINE (25 patients)
RISPERIDONE (24 patients)
GENTAMICIN (24 patients)
PHENYTOIN (23 patients)
AMANTADINE HCL (23 patients)
ACETAMINOPHEN (21 patients)
HALDOL (21 patients)
DIAZEPAM (20 patients)
VALTREX (20 patients)
OMEPRAZOLE (19 patients)
PAROXETINE HCL (19 patients)
ACETAMINOPHEN AND TRAMADOL HCL (18 patients)
CEFOTAXIME (18 patients)
SPIRONOLACTONE (18 patients)
LEVOTHYROXINE SODIUM (18 patients)
TEGRETOL (17 patients)
PREDNISOLONE (17 patients)
DEPAKENE (17 patients)
HALOPERIDOL (17 patients)
SIMVASTATIN (16 patients)
NITROGLYCERIN (16 patients)
ZOLOFT (15 patients)
PIPERACILLIN (15 patients)
LIPITOR (15 patients)
LEXOMIL (14 patients)
CLOPIDOGREL (14 patients)
OLANZAPINE (14 patients)
CABERGOLINE (14 patients)
TEMESTA (14 patients)
CLONAZEPAM (14 patients)
IBUPROFEN (14 patients)
NEURONTIN (13 patients)
LEVODOPA (13 patients)
WARFARIN SODIUM (13 patients)
SERENACE (13 patients)
OXYCONTIN (13 patients)
MEMANTINE HCL (13 patients)
ATENOLOL (13 patients)
DIOVAN (12 patients)
HIZENTRA (12 patients)
PRAMIPEXOLE DIHYDROCHLORIDE (12 patients)
ALBUTEROL (12 patients)
CELEBREX (12 patients)
HEPARIN (12 patients)
SEROQUEL XR (12 patients)
ENOXAPARIN SODIUM (12 patients)
ATORVASTATIN CALCIUM (12 patients)
ABILIFY (11 patients)
PLAVIX (11 patients)
FLUOXETINE (11 patients)
LOXAPINE HCL (11 patients)
COREG (11 patients)
TAXOTERE (11 patients)
GLEEVEC (11 patients)
VENLAFAXINE (11 patients)
PREVACID (11 patients)
CAPTOPRIL (11 patients)
CIPRO (11 patients)
CYCLOSPORINE (11 patients)
LANTUS (10 patients)
SYNTHROID (10 patients)
ACTONEL (10 patients)
MIRAPEX (10 patients)
KETOCONAZOLE (10 patients)
ANTIBIOTICS (10 patients)
ARICEPT (10 patients)
HEPARIN SODIUM INJECTION (10 patients)
AVONEX (10 patients)
RAMIPRIL (9 patients)
INSULIN (9 patients)
NECYRANE (9 patients)
MORPHINE (9 patients)
FERROUS SULFATE TAB (9 patients)
PRAZEPAM (9 patients)
DONEPEZIL HCL (9 patients)
CARBOCISTEINE (9 patients)
EXTAVIA (9 patients)
BROMOCRIPTINE MESYLATE (9 patients)
AMBIEN (9 patients)
AMOXICILLIN (9 patients)
RISPERDAL CONSTA (9 patients)
LAMICTAL (9 patients)
SINGULAIR (9 patients)
ECONAZOLE NITRATE (9 patients)
ARTANE (9 patients)
FOLIC ACID (9 patients)
PRAMIPEXOLE DIHYCHLLORIDE (9 patients)
LISINOPRIL (9 patients)
CEFUROXIME (9 patients)
LYSOPAINE (9 patients)
PRILOSEC (9 patients)
HYDROCHLOROTHIAZIDE (9 patients)
SANDIMMUNE (9 patients)
CYMBALTA (8 patients)
ELUDRIL (8 patients)
MIRTAZAPINE (8 patients)
SOLANAX (8 patients)
EPINEPHRINE (8 patients)
TYLENOL (CAPLET) (8 patients)
CIATYL Z (8 patients)
TRAMAL (8 patients)
AMIODARONE HCL (8 patients)
COUMADIN (8 patients)
NEUROCIL (8 patients)
OXAZEPAM (8 patients)
LEVEMIR (8 patients)
AVANDIA (8 patients)
NEXIUM (8 patients)
PROTONIX (8 patients)
ZOCOR (8 patients)
WELLBUTRIN (8 patients)
BIPERIDEN HYDROCHLORIDE TAB (8 patients)
METFORMIN HCL (7 patients)
NORVASC (7 patients)
METOPROLOL (7 patients)
TRIVASTAL (7 patients)
ZANAFLEX (7 patients)
HUMIRA (7 patients)
ALDACTONE (7 patients)
SOLU-CORTEF (7 patients)
ALLOPURINOL (7 patients)
TRIHEXYPHENIDYL HCL (7 patients)
PREVISCAN (7 patients)
DOPAMINE HCL (7 patients)
SERTRALINE HCL (7 patients)
THIOPENTAL SODIUM (7 patients)
ENALAPRIL MALEATE (7 patients)
BISOPROLOL FUMARATE (7 patients)
TRAZODONE HCL (7 patients)
LITHIUM CARBONATE (7 patients)
TYLENOL (7 patients)
TRANXENE (7 patients)
POTASSIUM CHLORIDE (7 patients)
CEFOTAXIME SODIUM (7 patients)
PREDONINE (7 patients)
ISOSORBIDE DINITRATE (7 patients)
CYTARABINE (7 patients)
VITAMIN D (7 patients)
CARBIDOPA AND LEVODOPA (6 patients)
LOVENOX (6 patients)
ACETYLSALICYLIC ACID SRT (6 patients)
ESCITALOPRAM (6 patients)
DEXAMETHASONE TAB (6 patients)
SERTRALINE HYDROCHLORIDE (6 patients)
EVEROLIMUS (6 patients)
TASMAR (6 patients)
ALPRAZOLAM (6 patients)
MANTADIX (6 patients)
PRAZINE (6 patients)
HERCEPTIN (6 patients)
DEROXAT (6 patients)
AMLODIPINE (6 patients)
METHYLPREDNISOLONE (6 patients)
PURSENNID (6 patients)
REMICADE (6 patients)
SILECE (6 patients)
ZOVIRAX (6 patients)
MYCOPHENOLATE MOFETIL (6 patients)
ARAVA (6 patients)
LEPTICUR (6 patients)
CARBAMAZEPINE (6 patients)
TOBRAMYCIN (6 patients)
SYMMETREL (6 patients)
ATIVAN (6 patients)
ATORVASTATIN (6 patients)
CIPRALEX (ESCITALOPRAM) (6 patients)
LYRICA (6 patients)
CLARITHROMYCIN (6 patients)
CITALOPRAM (6 patients)
VANCOMYCIN (6 patients)
HEPTAMINOL (6 patients)
AZILECT (6 patients)
HUMALOG (6 patients)
PREDNISONE TAB (6 patients)
PROPRANOLOL (6 patients)
PROCTOLOG (6 patients)
INTETRIX (6 patients)
RANITIDINE (6 patients)
MS CONTIN (5 patients)
Most common side effects for patients taking COMBIVIR:
DRUG EXPOSURE DURING PREGNANCY (2080 patients)
ABORTION SPONTANEOUS (479 patients)
ANAEMIA (473 patients)
PREMATURE BABY (374 patients)
PYREXIA (356 patients)
PREGNANCY (345 patients)
STILLBIRTH (339 patients)
VOMITING (277 patients)
DIARRHOEA (257 patients)
NAUSEA (234 patients)
ABORTION INDUCED (203 patients)
ALANINE AMINOTRANSFERASE INCREASED (194 patients)
MATERNAL EXPOSURE DURING PREGNANCY (183 patients)
FOETAL EXPOSURE DURING PREGNANCY (182 patients)
CAESAREAN SECTION (179 patients)
HAEMOGLOBIN DECREASED (176 patients)
ASTHENIA (171 patients)
FATIGUE (161 patients)
HEADACHE (160 patients)
SEPSIS (160 patients)
NEUTROPENIA (159 patients)
ABDOMINAL PAIN (158 patients)
DYSPNOEA (158 patients)
COUGH (151 patients)
CONGENITAL ANOMALY (143 patients)
MATERNAL DRUGS AFFECTING FOETUS (140 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (138 patients)
PANCYTOPENIA (136 patients)
HEPATITIS (135 patients)
CARDIAC MURMUR (131 patients)
PAIN IN EXTREMITY (125 patients)
DIZZINESS (122 patients)
ABDOMINAL DISTENSION (117 patients)
RASH (115 patients)
VENTRICULAR SEPTAL DEFECT (114 patients)
BLOOD BILIRUBIN INCREASED (113 patients)
JAUNDICE (112 patients)
INTRA-UTERINE DEATH (107 patients)
WEIGHT DECREASED (105 patients)
DRUG INTERACTION (104 patients)
HEPATOTOXICITY (103 patients)
CONFUSIONAL STATE (103 patients)
RENAL FAILURE (103 patients)
PNEUMONIA (102 patients)
MALAISE (102 patients)
EXOMPHALOS (101 patients)
PREMATURE LABOUR (101 patients)
ATRIAL SEPTAL DEFECT (101 patients)
ASCITES (96 patients)
POLYDACTYLY (95 patients)
TRISOMY 21 (95 patients)
RENAL FAILURE ACUTE (94 patients)
DEATH (92 patients)
NORMAL NEWBORN (92 patients)
PRE-ECLAMPSIA (90 patients)
ARTHRALGIA (86 patients)
DEPRESSION (83 patients)
OEDEMA PERIPHERAL (83 patients)
THROMBOCYTOPENIA (82 patients)
HEPATIC FAILURE (82 patients)
PRURITUS (82 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (80 patients)
CARDIAC MALPOSITION (80 patients)
AGITATION (79 patients)
PALLOR (78 patients)
TALIPES (76 patients)
LIVE BIRTH (76 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (75 patients)
DIAPHRAGMATIC APLASIA (75 patients)
DEFORMITY THORAX (73 patients)
DEHYDRATION (73 patients)
CHEST PAIN (73 patients)
PATENT DUCTUS ARTERIOSUS (73 patients)
HEPATIC ENZYME INCREASED (72 patients)
VANISHING BILE DUCT SYNDROME (72 patients)
ABDOMINAL PAIN UPPER (70 patients)
CYTOLYTIC HEPATITIS (70 patients)
MYOCARDIAL INFARCTION (70 patients)
PREMATURE RUPTURE OF MEMBRANES (70 patients)
OSTEONECROSIS (69 patients)
FOETAL GROWTH RETARDATION (69 patients)
MICROCEPHALY (67 patients)
RASH MACULO-PAPULAR (67 patients)
HEPATIC DISPLACEMENT (67 patients)
MYALGIA (66 patients)
CONVULSION (65 patients)
PAIN (64 patients)
RESPIRATORY DISTRESS (64 patients)
PANCREATITIS (63 patients)
HYPERSENSITIVITY (63 patients)
ULTRASOUND ANTENATAL SCREEN ABNORMAL (63 patients)
CRYPTORCHISM (63 patients)
PNEUMOTHORAX (62 patients)
HYPERLACTACIDAEMIA (61 patients)
LEUKOPENIA (61 patients)
LOSS OF CONSCIOUSNESS (60 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (60 patients)
DIABETES MELLITUS (59 patients)
PALPITATIONS (59 patients)
LIVER FUNCTION TEST ABNORMAL (59 patients)
SMALL FOR DATES BABY (58 patients)
PERICARDIAL EFFUSION (57 patients)
HYDRONEPHROSIS (57 patients)
BLOOD LACTIC ACID INCREASED (56 patients)
HEPATOMEGALY (56 patients)
CARDIOMYOPATHY (56 patients)
ANAEMIA MACROCYTIC (56 patients)
C-REACTIVE PROTEIN INCREASED (55 patients)
LACTIC ACIDOSIS (55 patients)
GASTROENTERITIS (55 patients)
HYPERTRIGLYCERIDAEMIA (54 patients)
NEPHROLITHIASIS (54 patients)
ANOREXIA (52 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (51 patients)
NEUROPATHY PERIPHERAL (51 patients)
STEVENS-JOHNSON SYNDROME (50 patients)
IMMUNE RECONSTITUTION SYNDROME (50 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (50 patients)
LYMPHADENOPATHY (49 patients)
NEONATAL DISORDER (49 patients)
GASTROINTESTINAL DISORDER (49 patients)
TACHYCARDIA (49 patients)
EATING DISORDER (49 patients)
BONE MARROW FAILURE (49 patients)
CHOLELITHIASIS (48 patients)
DEVELOPMENTAL DELAY (48 patients)
CARDIAC FAILURE (47 patients)
TRANSAMINASES INCREASED (47 patients)
HYDROPS FOETALIS (47 patients)
DRUG TOXICITY (47 patients)
LABORATORY TEST ABNORMAL (47 patients)
SCLERAL DISCOLOURATION (46 patients)
HYPERTENSION (46 patients)
FOETAL GROWTH RESTRICTION (46 patients)
INSOMNIA (46 patients)
DECREASED APPETITE (46 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (46 patients)
ALPHA 1 FOETOPROTEIN ABNORMAL (45 patients)
HYPOTENSION (45 patients)
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY (44 patients)
SOMNOLENCE (44 patients)
HYPERBILIRUBINAEMIA (44 patients)
HYPONATRAEMIA (44 patients)
PLACENTAL DISORDER (43 patients)
DRUG INEFFECTIVE (43 patients)
FOETAL DISORDER (43 patients)
PANCREATITIS ACUTE (43 patients)
ABDOMINAL HERNIA (42 patients)
DEATH NEONATAL (42 patients)
OEDEMA (42 patients)
PREMATURE SEPARATION OF PLACENTA (42 patients)
DYSPNOEA EXERTIONAL (41 patients)
CHILLS (41 patients)
CARDIAC FAILURE CONGESTIVE (41 patients)
URTICARIA (40 patients)
DRUG HYPERSENSITIVITY (40 patients)
ERYTHEMA (40 patients)
LIPODYSTROPHY ACQUIRED (40 patients)
ENCEPHALITIS (40 patients)
BLOOD AMYLASE INCREASED (40 patients)
RESPIRATORY FAILURE (39 patients)
BLOOD CREATININE INCREASED (39 patients)
BACK PAIN (39 patients)
HYDROCEPHALUS (39 patients)
WHITE BLOOD CELL COUNT DECREASED (39 patients)
HYPOTONIA (38 patients)
TOXIC EPIDERMAL NECROLYSIS (38 patients)
HEPATIC CIRRHOSIS (37 patients)
HEART DISEASE CONGENITAL (37 patients)
ANXIETY (37 patients)
CYTOMEGALOVIRUS INFECTION (37 patients)
LIPASE INCREASED (37 patients)
STAPHYLOCOCCAL INFECTION (36 patients)
HEPATIC STEATOSIS (36 patients)
SPINA BIFIDA (36 patients)
CD4 LYMPHOCYTES DECREASED (36 patients)
CEREBRAL TOXOPLASMOSIS (35 patients)
ULTRASOUND SCAN ABNORMAL (35 patients)
HYPOAESTHESIA (35 patients)
MITOCHONDRIAL CYTOPATHY (34 patients)
LIVER DISORDER (34 patients)
ACUTE RESPIRATORY FAILURE (34 patients)
SPLENOMEGALY (34 patients)
PYELOCALIECTASIS (34 patients)
FOETAL DISTRESS SYNDROME (34 patients)
CHOLANGITIS (34 patients)
VISION BLURRED (34 patients)
BIOPSY LIVER ABNORMAL (34 patients)
MALARIA (34 patients)
MACROCYTOSIS (33 patients)
RASH ERYTHEMATOUS (33 patients)
CONGENITAL HEPATOBILIARY ANOMALY (32 patients)
METHYLMALONIC ACIDURIA (32 patients)
DYSPHAGIA (32 patients)
PULMONARY EMBOLISM (32 patients)
ADRENOGENITAL SYNDROME (32 patients)
LETHARGY (32 patients)
CARDIOMEGALY (32 patients)
ALPHA 1 FOETOPROTEIN INCREASED (32 patients)
TREATMENT NONCOMPLIANCE (32 patients)
RASH GENERALISED (32 patients)
SHOCK (31 patients)
MULTIPLE CONGENITAL ABNORMALITIES (30 patients)
RENAL DISORDER (30 patients)
MENINGOMYELOCELE (30 patients)
CONDITION AGGRAVATED (30 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (30 patients)
PULMONARY ARTERY STENOSIS CONGENITAL (30 patients)
CHORIOAMNIONITIS (30 patients)
METABOLIC ACIDOSIS (29 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for COMBIVIR


Issue Description / Topic Timestamp
QUESTION
CONGENITAL MYOPATHY
Has anyone experienced myopathy after being treated for 28 days with the drug Combivir? 2016-11-23 19:57:49

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about AKINESIA and COMBIVIR, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking COMBIVIR, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in COMBIVIR. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for COMBIVIR experts. If you are a healthcare provider experienced in prescribing COMBIVIR, please register here.
giCould not connect: